HomeExperiments
Track active studies, experimental execution, protocol progress, ownership, and review readiness.
Execution stages across the research portfolio
6 visible studies · select a row for execution context
| Experiment / Study ID | Asset | Study Name | Cancer Model | Protocol | Owner | Current Stage | Progress | Next Milestone | Due Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| BC-001 | OGC-2401 | Breast Cancer Spheroid Response StudyBreast Cancer | TNBC, HER2- | OG-PROT-3D-021 | Dr. S. Mokoena | Response Analysis | 82% | Scientific Review | 2026-10-08 | On Track |
| BC-002 | OGC-BC-118 | Dose Response ValidationBreast Cancer | HR+ / HER2+ | OG-PROT-3D-025 | Dr. J. Patel | Treatment | 46% | Day 7 Imaging | 2026-10-11 | On Track |
| GBM-004 | OGC-NS-321 | Glioblastoma Penetration StudyGlioblastoma | IDH-wildtype | OG-PROT-ORG-012 | Dr. M. Rossi | Imaging | 63% | QC Review | 2026-10-07 | Needs Attention |
| LU-003 | OGC-LU-104 | NSCLC PROTAC Response StudyLung Cancer | NSCLC | OG-PROT-3D-030 | Dr. A. Kumar | QC Review | 54% | Treatment completion | 2026-10-12 | Blocked |
| OV-006 | OGC-OV-207 | Ovarian Signature ValidationOvarian Cancer | High-grade serous | OG-PROT-ORG-018 | Dr. L. Chen | Scientific Review | 91% | Independent sign-off | 2026-10-09 | On Track |
| PA-002 | OGC-PA-084 | PDAC Stromal Response StudyPancreatic Cancer | PDAC | OG-PROT-CO-008 | Dr. S. Mokoena | Approved | 100% | Archive protocol | 2026-10-04 | Completed |
Execution calendar
Assigned to Dr. Sarah Mokoena